🇺🇸 FDA
Patent

US 12043655

Constitutively active chimeric cytokine receptors

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 12043655 (Constitutively active chimeric cytokine receptors) held by Allogene Therapeutics, Inc. expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Allogene Therapeutics, Inc.
Grant date
Tue Jul 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K40/11